---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-056294"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:23:15.390659+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma implements 1-for-50 reverse stock split in preparation for Nasdaq uplisting

## Summary
- Reverse split at ratio of 1-for-50 effective 4:01 p.m. ET on September 14, 2022.
- Common stock will trade on OTC Markets under temporary symbol 'SILOD' until Nasdaq listing.
- Post-split shares outstanding approximately 1,987,906; fractional shares rounded up.
- Stockholders approved reverse split range at special meeting on March 11, 2022.
- Company has filed Nasdaq listing application and believes it meets all requirements except minimum share price.

## SEC filing metadata
- accession: 0001213900-22-056294
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390022056294/0001213900-22-056294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390022056294/ea165863-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-056294
- JSON: https://secwatch.observer/filing/0001213900-22-056294.json
- Plain text: https://secwatch.observer/filing/0001213900-22-056294.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.